AbbVie Inc (NYSE:ABBV) Holdings Cut by Capital Planning Advisors LLC

Saturday, 10 Feb, 2018

Epoch Investment Partners Inc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $177.68B market cap company. The stock increased 2.60% or $2.82 during the last trading session, reaching $111.3. The shares were sold at an average price of $98.45, for a total transaction of $8,569,088.00. Harfst & Associates Inc. purchased a new stake in AbbVie in the 4th quarter worth $214,000. It has underperformed by 25.91% the S&P500.

Key Group Holdings Cayman Ltd decreased its stake in Eqt Corp (EQT) by 11.91% based on its latest 2017Q3 regulatory filing with the SEC. Ing Groep Nv sold 72,809 shares as the company's stock rose 6.17% with the market. Senzar Asset Management Llc who had been investing in Corium Intl Inc for a number of months, seems to be less bullish one the $439.94M market cap company. The stock decreased 1.12% or $0.52 during the last trading session, reaching $45.73. The shares were sold at an average price of $96.71, for a total value of $14,072,272.10. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 10, 2017 and is uptrending. It has underperformed by 6.07% the S&P500. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company's stock. Therefore 48% are positive. (NYSE:ABBV). Optimum Investment Advsr holds 1.33% or 44,565 shares in its portfolio. SALEKI-GERHARDT AZITA sold $705,655 worth of AbbVie Inc.

AbbVie (NYSE:ABBV) last posted its earnings results on Friday, January 26th. The firm has "Hold" rating given on Tuesday, September 5 by Cowen & Co. Mn Services Vermogensbeheer B.V. now owns 260,590 shares of the company's stock worth $18,895,000 after buying an additional 217,244 shares during the period. Leerink Swann downgraded AbbVie from an "outperform" rating to a "market perform" rating and set a $127.00 price objective for the company.in a research note on Monday, January 29th. (NYSE:ABBV) has "Buy" rating given on Tuesday, February 23 by Citigroup. (NYSE:ABBV) or 110,397 shares. Argus boosted their price objective on AbbVie from $120.00 to $145.00 and gave the stock a "buy" rating in a research note on Friday, February 2nd. Deutsche Bank initiated it with "Hold" rating and $63 target in Tuesday, March 15 report.

Shares of AbbVie Inc. Finally, Credit Suisse Group set a $135.00 price objective on AbbVie and gave the stock a "hold" rating in a report on Monday, January 29th.

Investors sentiment decreased to 0.85 in Q3 2017. The company reported $1.48 EPS for the quarter, topping analysts' consensus estimates of $1.44 by $0.04. It worsened, as 55 investors sold ABBV shares while 640 reduced holdings.

Several hedge funds and other institutional investors have recently made changes to their positions in the business. M reported 11,250 shares. (NYSE:ABBV) for 71,733 shares. New Vernon Investment Mngmt Ltd owns 0.63% invested in JPMorgan Chase & Co. 6,699 AbbVie Inc. (NYSE:ABBV) shares with value of $589,512 were sold by Michael Robert A. Gosebruch Henry O also sold $1.66 million worth of AbbVie Inc. Marshwinds Advisory stated it has 33,657 shares or 1.39% of all its holdings. Montag A & invested in 69,815 shares. Alpha Cubed Lc reported 49,670 shares.

TRADEMARK VIOLATION WARNING: "AbbVie Inc (NYSE:ABBV) Holdings Cut by Capital Planning Advisors LLC" was first published by The Lincolnian Online and is the property of of The Lincolnian Online.

Van Hulzen Asset Management Llc, which manages about $396.50M and $296.46 million US Long portfolio, decreased its stake in Schlumberger (NYSE:SLB) by 28,270 shares to 2,954 shares, valued at $206,000 in 2017Q3, according to the filing. Gsa Capital Prtn Llp has invested 0.02% in AbbVie Inc. 192,210 were reported by Amalgamated Bancorporation. Orbis Allan Gray Ltd now owns 12,704,919 shares of the company's stock worth $921,233,000 after buying an additional 3,340,038 shares during the period. Lombard Odier Asset Management (Switzerland) invested in 2.12% or 245,560 shares.

Investors sentiment increased to 1.08 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. 65 funds opened positions while 204 raised stakes. 184.83 million shares or 6.77% more from 173.11 million shares in 2017Q2 were reported. Kings Point Cap Management has 288 shares. Virtu Limited Liability, a New York-based fund reported 11,922 shares. Woodmont Invest Counsel holds 0.32% or 21,327 shares. Gillespie Robinson & Grimm Inc holds 0.09% or 7,583 shares. 387.06 million shares or 0.01% more from 387.02 million shares in 2017Q2 were reported. Cove Street Limited Liability Corp holds 0.01% or 1,500 shares in its portfolio. Capital Advisers Limited Com stated it has 0.11% of its portfolio in EQT Corporation (NYSE:EQT). Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 539,799 shares or 0.45% of the stock. Weatherly Asset Mgmt LP invested 0.27% in AbbVie Inc. Ifc Fl accumulated 25,115 shares or 0.16% of the stock. Mycio Wealth Prns Ltd owns 8,635 shares for 0.05% of their portfolio. Orbis Allan Gray Ltd grew its position in shares of AbbVie by 35.7% during the 2nd quarter. Therefore 29% are positive. JPMorgan Chase & Co had 109 analyst reports since July 21, 2015 according to SRatingsIntel. Morgan Stanley has "Overweight" rating and $133 target. The stock has "Buy" rating by Stifel Nicolaus on Tuesday, May 2. The stock has "Equal-Weight" rating by Barclays Capital on Friday, October 13. The firm earned "Buy" rating on Tuesday, August 11 by TheStreet. The rating was maintained by BMO Capital Markets on Wednesday, June 7 with "Hold". The firm has "Buy" rating by Jefferies given on Thursday, July 13. The company presently has a consensus rating of "Buy" and a consensus target price of $82.38. SunTrust maintained it with "Buy" rating and $105.0 target in Sunday, October 29 report.

Since August 21, 2017, it had 1 insider purchase, and 10 insider sales for $23.24 million activity. 558 shares valued at $31,761 were bought by Cary A. Bray Jr. on Monday, January 1.